461-81-4 | Sigma-Aldrich

CYCLOHEXIMIDE READY MAD

Hausler WJ, Shadomy HJ (eds), Washington DC, ASM, pp 500-584, (1985). 4. Lin W-W and Hsu Y-W, Cell. Signaling, 12, 457- 461 (2000). 5. Mizel SB and Mizel D, J. Immunology, 126, 834- 837, (1981).

Reprogramming Application Note Human Non-inducible OSLN

Kupriyanov S, Baldwin KK. Adult mice generated from induced pluripotent stem cells. (2009) Nature. 461(7260): 91-4. 7. Kang L, Wang J, Zhang Y, Kou Z andGao S. iPS cells can support full-term development of

Data Sheet - P2482

mouse immunized with a synthetic peptide corresponding to the carboxy- terminal sequence (amino acids 461-477) of human PKBα/Akt1, conjugated to KLH. The isotype is determined using Sigma ImmunoType Kit (

QC Range Sheet MCKP1-110K

/mL Control 2 502 - 1042 pg/ml CTLA-4/CD152 Control 1 57 - 117 pg/mL 4-1BBL/TNF SF9 Control1 99 - 205 pg/ml Control 2

Quality Control Range Sheet- PCC-124 and PCC-224

Corporation, Billerica, MA 01821 USA   GM-CSF Control 1 66 - 137 pg/mL IL-4 Control 1 123 - 255 pg/mL Control 2 461 - 957 pg/mL Control 2 965 - 2004 pg/mL

Anti-Calnexin (C4731)

resident ER proteins involved in Ca2+-dependent retention of proteins. Calnexin contains a long (461 amino acids) N-terminal Ca2+-binding domain extending into the lumen of the ER, a short (22 amino

Data Sheet - P4112

rabbit using a synthetic phosphorylated peptide corresponding to (pSer473) PKBα (human, amino acids 461-477 with N-terminally added lysine), conjugated to KLH as immunogen. This sequence is identical in

XP725 Antibody Number-Lot Number 071M4826

e-f g-h a-b c-d e-f g-h 1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80 1.3

Product Information Sheet - 330003S

TopFluor™ can be used in combi- nation with Hoechst 33342 (Ex/Em = 346/497 nm) or DAPI (Ex/Em = 358/461 nm) nuclear staining and probes with fluorophores that emit at 578 nm and 670 nm using rhodamine and

PKH Dye Reference Guide

66, 81, 99, 111, 116, 128, 129, 145, 155, 172, 207 Recirculation, cellular lifetime 94, 150, 200, 207, 208 Proliferation, growth control 29, 126, 130 Differentiation, embryogenesis 4, 9

33103-93-4 15210-60-3 80121-67-1 119478-56-7 1053703-36-8 89-57-6 591-27-5 95-55-6 19767-45-4 5907-38-0 1672-58-8 83-07-8 856307-27-2 58-15-1 1115-70-4 461-58-5

Materiales de Laboratorio Catálogo

23,000 461 WHAT99-293-150 Merck FILTER PAPER GRADE 589/2, PACK OF 100 CLP 44,000 3 WHAT10300111 Merck FILTER PAPER,CIRCLE,GRADE 1, 70MM CLP 8,850 9 WHAT1001-070 Merck FILTER PAPER,CIRCLE,GRADE 4, 150MM

Acta Volume 49 Number 3

Vallgårda, J.; Appelberg, U.; Csöregh, I.; Hacksell, U. J. Chem. Soc., Perkin Trans. 1 1994, 461. (47) Vinš, P.; de Cózar, A.; Rivilla, I.; Nováková, K.; Zangi, R.; Cvačka, J.; Arrastia, I.;

TB534 WideScreenﾙ BeadPlexﾙ Phospho-EGFR Profiling Panel 9-Plex Complete Assay Kit

Countries Tel (800) 628-8470 bioscienceshelp@ emdchemicals.com France Freephone 0800 126 461 Germany Freecall 0800 100 3496 Ireland Toll Free 1800 409 445 United Kingdom

Bioreactor Systems for Bone Tissue Engineering

Grad, S., Eglin, D., and Alini, M. Cells and biomaterials in cartilage tissue engineering. Regen Med 4, 81, 2009. 6. Lv, S., et al. Designed biomaterials to mimic the mechanical properties of muscles. Nature

Research Article: MCP-1, KC-like and IL-8 as critical mediators of

-Max 130–220 104–969 22–187 31–119 35–5019 1–2106 12–342 2–490 163–436 Median 143 330 89 51 601 461 111 145 224 SD 29 282 44 26 1477 527 110 180 95 Complicated day 1 (n = 18)

XP725 Antibody List Lot 129K4831

P0084 5411 PNN M NP_002678.2 y n/d n/d 38 ARTS A3720 5414 4-Sep P NP_001185642.1 y n/d n/d 39 ARTS A4471 5414 4-Sep M NP_001185642.1 y n/d n/d 461 a-MSH M0939 5443 POMC P NP_000930.1 , NP_001030333.1 y

XP725 Antibody List Lot 129K4830

P0084 5411 PNN M NP_002678.2 y n/d n/d 38 ARTS A3720 5414 4-Sep P NP_001185642.1 y n/d n/d 39 ARTS A4471 5414 4-Sep M NP_001185642.1 y n/d n/d 461 a-MSH M0939 5443 POMC P NP_000930.1 , NP_001030333.1 y

XP725 Antibody List Lot 089K4791

P0084 5411 PNN M NP_002678.2 y n/d n/d 38 ARTS A3720 5414 4-Sep P NP_001185642.1 y n/d n/d 39 ARTS A4471 5414 4-Sep M NP_001185642.1 y n/d n/d 461 a-MSH M0939 5443 POMC P NP_000930.1 , NP_001030333.1 y

Halal Certificate

ALCOHOL 98% W229407 B68364 HC-23SI8818 460. CINNAMYL BENZOATE, 98%, FG W470301 A89117 HC-23SIOI46 461. CINNAMYL CINNAMATE, MIXTURE OF ISOMERS W229806 C47741 HC-23SI6O46 462. Cinnamyl Isobutyrate W229709

Halal Certificate

ALCOHOL 98% W229407 B68364 HC-22SI8P39 460. CINNAMYL BENZOATE, 98%, FG W470301 A89117 HC-22SI9G67 461. CINNAMYL CINNAMATE, MIXTURE OF ISOMERS W229806 C47741 HC-22SIJ767 462. Cinnamyl Isobutyrate W229709

inNovations Newsletter #15

Science 284, 455–461. 2. Shuman, S. (1990) J. Biol. Chem. 265, 11960–11966. 3. Li, C., Schwabe, J. W., Banayo, E., and Evans, R. M. (1997) Proc. Natl. Acad. Sci. USA 94, 2278–2283. 4. Ishiai, M.

List of Antibodies

B0686 P y n/d n/d 81 BUB1 B0561 M y n/d n/d 82 BUBR1 B9310 M y n/d n/d 83 c-Abl A5844 M y y y 84 c-Cbl C9603 P y n/d n/d 85 c-erbB-2 E2777 M y n/d n/d 86 c-erbB-3 E8767 M y n/d

XP725 Worksheet for Lot Number 071M4826

Decarboxylase D0180 459 3 2 4 3 DP2 D7438 460 3 2 4 4 DP2 D7438 461 3 2 4 5 DR3 D3563 462 3 2 4 6 DR3 D3563 463 3 2 4 7 Negative Control NA 464 3 2 4 8 Negative Control NA 465

XP725 Antibody List

459 MRP1 M9192 4363 ABCC1 NP_063955.2 M y n/d n/d 460 MRP2 M3692 1244 ABCC2 NP_000383.1 M y n/d n/d 461 α-MSH M0939 5443 POMC NP_001030333.1 P y n/d n/d 462 MSH6 M2445 2956 MSH6 NP_000170.1 P y y y 463 MSH6

XP725 Antibody List 013M4793

459 MRP1 M9192 4363 ABCC1 NP_063955.2 M y n/d n/d 460 MRP2 M3692 1244 ABCC2 NP_000383.1 M y n/d n/d 461 α-MSH M0939 5443 POMC NP_001030333.1 P y n/d n/d 462 MSH6 M2445 2956 MSH6 NP_000170.1 P y y y 463 MSH6

Operating Manual Spectroquant® Colorimeter Move 100

temperature (°C or °F) for Langelier mode 70 5 .8 80 LCD contrast Setting the display contrast 3 .4 81 LCD brightness Setting the display brightness 3 .5 91 System-Info Information on the Move 100